Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lessons from TGN1412.

× No keyword cloud information.

21 in total

1. The storm has cleared: lessons from the CD28 superagonist TGN1412 trial.

Authors: Thomas Hünig
Journal: Nat Rev Immunol Date: 2012-04-10 Impact factor: 53.106

2. Human in vitro models of ischaemic stroke: a test bed for translation.

Authors: Ana Antonic; Emily S Sena; Geoffrey A Donnan; David W Howells
Journal: Transl Stroke Res Date: 2012-07-21 Impact factor: 6.829

Review 3. Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway.

Authors: Andrew B Adams; Mandy L Ford; Christian P Larsen
Journal: J Immunol Date: 2016-09-15 Impact factor: 5.422

Review 4. The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation.

Authors: Mark F Coughlin; Roger D Kamm
Journal: Adv Healthc Mater Date: 2020-01-29 Impact factor: 9.933

5. Primate testing of TGN1412: right target, wrong cell.

Authors: M Pallardy; T Hünig
Journal: Br J Pharmacol Date: 2010-10 Impact factor: 8.739

Review 6. [Drug trials in humans. Risks in the light of the London catastrophe].

Authors: A Otte
Journal: Internist (Berl) Date: 2007-06 Impact factor: 0.743

7. Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys.

Authors: Yiting Zhang; Jianhua Sun; Minjia Tan; Yongzhen Liu; Qian Li; Hua Jiang; Huamao Wang; Zonghai Li; Wei Wan; Hualiang Jiang; Henglei Lu; Bingshun Wang; Jin Ren; Likun Gong
Journal: Mol Ther Date: 2018-04-07 Impact factor: 11.454

8. The Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis.

Authors: Katherine A High
Journal: Trans Am Clin Climatol Assoc Date: 2009

9. Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28.

Authors: Nicolas Poirier; Caroline Mary; Stephanie Le Bas-Bernardet; Veronique Daguin; Lyssia Belarif; Melanie Chevalier; Jeremy Hervouet; David Minault; Simon Ville; Vianney Charpy; Gilles Blancho; Bernard Vanhove
Journal: MAbs Date: 2014-03-05 Impact factor: 5.857

10. Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.

Authors: Tea Gogishvili; Daniela Langenhorst; Fred Lühder; Fernando Elias; Karin Elflein; Kevin M Dennehy; Ralf Gold; Thomas Hünig
Journal: PLoS One Date: 2009-02-27 Impact factor: 3.240